Indeed, silencing PAK1 by shRNA or a specific inhibitor IPA-3 significantly suppresses ESCC cell proliferation, focus formation, anchorage-independent growth, migration, invasion and the expression of MMP-2 and MMP-9 in vitro. This evidence concerns the gene MMP9 and esophageal squamous cell carcinoma.